Page 83 - MI-2-1
P. 83

Microbes & Immunity                                                    Childhood brucellosis in Saudi Arabia



            prescribed to patients older than 9 years (except for one   Acknowledgments
            4-year-old who was given doxycycline). Recent evidence
            suggests that doxycycline can be safely given to children   We  thank  the  IT  department  and  the  immunology
            and pregnant women.  A thorough retrospective analysis   laboratory of King Abdulaziz University Hospital
                             26
            of 1843 newborns with prenatal doxycycline exposure   for providing the lists of patients. We also thank the
            revealed no greater risk of birth defects or teratogenic risks   microbiology  and  immunology  laboratory  for  their
            when compared to those who were not exposed.  These   assistance with the methods section.
                                                    27
            findings suggest that the advantages  of doxycycline use   Funding
            in young patients may outweigh the possible risks when
            treating specific diseases without effective alternatives or   None.
            when doxycycline is considered the treatment of choice, as
            in the case of brucellosis. 28                     Conflict of interest
              Ciprofloxacin may be beneficial for brucellosis in   Abrar K. Thabit is an Editorial Board Member of this
            cases of drug resistance when used in combination with   journal but was not in any way involved in the editorial
            rifampin. 29,30  The patient who had neurobrucellosis was   and peer-review process conducted for this paper, directly
            treated with a combination of doxycycline, trimethoprim/  or indirectly. Separately, other authors declared that they
            sulfamethoxazole,  and  ceftriaxone.  Per  a  previous   have no known competing financial interests or personal
            report, doxycycline and trimethoprim/sulfamethoxazole   relationships that could have influenced the work reported
            have been found to be effective in neurobrucellosis.    in this paper.
                                                         31
            Furthermore,  third-generation cephalosporins  with the   Author contributions
            ability to diffuse through the central nervous system,
            such as ceftriaxone, have shown good  in vitro activity   Conceptualization: Abrar K. Thabit
            against isolates of  B. melitensis.  The Saudi guidelines   Formal analysis: Abrar K. Thabit, Manar O. Lashkar
                                       32
            recommend  a  regimen  of  doxycycline,  trimethoprim/  Investigation: Renad S. Nahhas, Zain Y. Nemer, Zahra I.
            sulfamethoxazole, and rifampin to treat neurobrucellosis.   Askar, Walaa H. Alzahrani
            They also discussed the advantages of using ceftriaxone   Writing-original draft: Renad S. Nahhas, Zain Y. Nemer,
            in the initial therapy of neurobrucellosis in children older   Zahra I. Askar, Walaa H. Alzahrani, Sarah O. Alreeshi,
            than 8 years. 7                                       Manar O. Lashkar
              In our study, even though a clinical cure was achieved,   Writing-review & editing:  Abrar K. Thabit, Manar O.
            the patient’s antibody titers persisted after treatment   Lashkar.
            was completed. The results of an earlier retrospective   Ethics approval and consent to participate
            investigation that found that  Brucella serology did not
            correlate with clinical outcomes at the end-of-treatment   Ethical approval was obtained from the Research
            follow-up provide an explanation for this. Consequently,   Committee of the Unit of Biomedical Ethics, Faculty of
            rather  than depending exclusively on  serological results   Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
            during follow-up, clinicians should take into account the   (reference no. 128-18), who waived the need for informed
            full clinical picture of the brucellosis patient and evaluate   consent.
            the attainment of a clinical cure based on the disappearance
            of baseline signs and symptoms. 20                 Consent for publication
              This study has a few limitations. As a retrospective   As this was a retrospective study (old data of patients who
            study, some data were unavailable. It was also conducted in   have been discharged from the hospital), such consent was
            a single center and included a small sample size; thus, the   not obtained and could not be obtained given the nature
            results might not be generalizable.                of the study.
            5. Conclusion                                      Availability of data

            Our study described the characteristics of children   Data are available from the corresponding author upon
            diagnosed with brucellosis in an academic hospital,   request.
            highlighting typical signs and symptoms of fever, arthralgia,   Further disclosure
            and elevated liver enzymes. We emphasize that using a
            combination of at least two antibiotics effective against   The study abstract was published in the abstract book
            Brucella spp. is important for ensuring clinical success.  of the European Congress of Clinical Microbiology


            Volume 2 Issue 1 (2025)                         75                               doi: 10.36922/mi.4634
   78   79   80   81   82   83   84   85   86   87   88